Kolliphor® HS 15 Micelles for the Delivery of Coenzyme Q10: Preparation, Characterization, and Stability

AAPS PharmSciTech

Volumn 17, Issue 3, 2016, Pages 757-766

  Liu, Li ^a,b   Mao, Kai ^a,b   Wang, Wenting ^a,b   Pan, Hongchun ^a,b   Wang, Fen ^c   Yang, Min ^d   Liu, Hong ^a,b  

^a SOUTHWEST UNIVERSITY   (China)

^b Chongqing Engineering Research Center for Pharmaceutical Process and Quality Control   (China)

^c Jiangsu Simcere Pharmaceutical RandD Co Ltd   (China)

^d Sichuan Kelun Pharmaceutical Research Ltd   (China)

Author keywords

coenzyme Q10; Kolliphor HS 15; micelles; preparation; stability

Indexed keywords

UBIDECARENONE; KOLLIPHOR HS 15; MACROGOL DERIVATIVE; MICELLE; STEARIC ACID DERIVATIVE; UBIQUINONE;

ARTICLE; CRITICAL MICELLE CONCENTRATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG STABILITY; DRUG SYNTHESIS; HEMOLYSIS; HUMIDITY; PARTICLE SIZE; PH; PRIORITY JOURNAL; SHELF LIFE; TEMPERATURE; THERMOSTABILITY; ZETA POTENTIAL; ANALOGS AND DERIVATIVES; ANIMAL; CHEMISTRY; DRUG EFFECTS; ERYTHROCYTE; MEDICINAL CHEMISTRY; MICELLE; PHYSIOLOGY; PROCEDURES; RABBITS AND HARES;

ANIMALS; CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; DRUG STABILITY; ERYTHROCYTES; MICELLES; POLYETHYLENE GLYCOLS; RABBITS; STEARATES; UBIQUINONE;

EID: 84940826162     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-015-0399-5     Document Type: Article

References (47)

1. Bonakdar RA, Guarneri E. Coenzyme Q10. Am Fam Physician. 2005;72:1065–70.
2. Ebadi M, Muralikrishnan D, Pellett LJ, et al. Ubiquinone (coenzyme Q10) and complex I in mitochondrial oxidative disorder of Parkinson’s disease. Proc West Pharmacol Soc. 2000;43:55–63.
3. Aberg F, Appelkvist EL, Broijersen A, et al. Gemfibrozil-induced decrease in serum ubiquinone and α- and γ-tocopherol levels in men with combined hyperlipidaemia. Eur J Clin Investig. 1998;28:235–42.
4. Al Gadban MM, Smith KJ, Soodavar F, et al. Differential trafficking of oxidized LDL and oxidized LDL immune complexes in macrophages: impact on oxidative stress. PLoS One. 2010;5:1–10.
5. Turunen M, Olsson J, Dallner G. Metabolism and function of coenzyme Q. BBA-Biomembr. 2004;1600:171–99.
6. Hsu CH, Cui ZR, et al. Preparation and characterization of novel coenzyme Q10 Nanoparticles engineered from microemulsion precursors. AAPS PharmSciTech. 2003;4:1–12.
7. Shin JY, Shin JI, Kim JS, et al. Assembly of Coenzyme Q10 nanostructure resembling nascent discoidal high density lipoprotein particle. Biochem Biophys Res Commun. 2009;388:217–21.
8. Bhandari KH, Newa M, Kim JA, et al. Preparation, characterization and evaluation of coenzyme Q10 binary solid dispersions for enhanced solubility and dissolution. Biol Pharm Bull. 2007;30:1171–6.
9. Nehilla BJ, Bergkvist M, Popat KC, et al. Purified and surfactant-free coenzyme Q10-loaded biodegradable nanoparticles. Int J Pharm. 2008;348:107–14.
10. Swarnakar NK, Jain AK, Singh RP, et al. Oral bioava ilability, therapeutic efficacy and reactive oxygen species scavenging properties of coenzyme Q10-loaded polymeric nanoparticles. Biomaterials. 2011;32:6860–74.
11. Kwon SS, Nam YS, Lee JS, et al. Preparation and characterization of coenzyme Q10-loaded PMMA nanoparticles by a new emulsification process based on microfluidization. Colloid Surf A. 2002;210:95–104.
12. Ray R, Kibbe AH, Rowe R, et al. Handbook of pharmaceutical excipients. Washington, DC: APhA Publications; 2003.
13. Barratt GM. Therapeutic applications of colloidal drug carriers. Pharm Sci Technol Today. 2000;3:163–71.
14. Owen SC, Chan D, Shoichet MS. Polymeric micelle stability. Nano Today. 2012;7:53–65.
15. Ten Tije AJ, Verweij J, Loos WJ, et al. Pharmacological effects of formulation vehicles: implications for cancer chemotherapy. Clin Pharmacokinet. 2003;42:665–85.
16. Coon JS, Knudson W, Clodfelter K, et al. Solutol HS15, nontoxic polyoxyethylene esters of 12-hydroxystearic acid, reverses multidrug resistance. Cancer Res. 1991;51:897–902.
17. Ku S, Velagaleti R. Solutol HS15 as a novel excipient, Pharm Technol. 2010. Solutol HS15 as a novel excipient, Pharm Technol. Accessed 2 Nov 2010.
18. Alani Adam WG, Rao DA, Seidel R, et al. The effect of novel surfactants and solutol® HS15 on paclitaxel aqueous solubility and permeability across a caco-2 monolayer. J Pharm Sci. 2010;99:3473–85.
19. Seo SW, Han HK, Chun MK, et al. Preparation and pharmacokinetic evaluation of curcumin solid dispersion using Solutol® HS15 as a carrier. Int J Pharm. 2012;424:18–25.
20. Ahmad J, Mir SR, Kohli K, et al. Effect of oil and co-surfactant on the formation of Solutol HS15 based colloidal drug carrier by Box–Behnken statistical design. Colloid Surf A. 2014;453:68–77.
21. Bittner B, Gonzalez RCB, Walter I, et al. Impact of Solutol HS15 on the pharmacokinetic behaviour of colchicine upon intravenous administration to male wistar rats. Biopharm Drug Dispos. 2003;24:173–81.
22. Cornaire G, Woodley J, Hermann P, et al. Impact of excipients on the absorption of P- glycoprotein substrates in vitro and in vivo. Int J Pharm. 2004;278:119–31.
23. Rupp C, Steckel H, Mueller BW. Solubilization of poorly water-soluble drugs by mixed micelles based on hydrogenated phosphatidylcholine. Int J Pharm. 2010;395:272–80.
24. Qiu LP, Qiao MX, et al. Enhanced effect of pH -sensitive mixed copolymer micelles for overcoming multidrug resistance of doxorubicin. Biomaterials. 2014;35:9877–87.
25. Wang CT, Ji BQ, Cao YP, et al. Preparation and evaluation of lipid nanoparticles for loading enzyme subtilisin FS3. Food Sci. 2008;29:158–61.
26. Yang M, Liu L, Su QJ, et al. Preparation and characterization of creatine phosphate sodium. Lat Am J Pharm. 2014;33:658–65.
27. Sezgin Z, Yuksel N, Baykara T. Preparation and characterization of polymeric micelles for solubilization of poorly soluble anticancer drugs. Eur J Pharm Biopharm. 2006;64:261–8.
28. Zhai YG, Guo SS, Liu CH, et al. Preparation and in vitro evaluation of apigenin-loaded polymeric micelles. Colloid Surf A. 2013;429:24–30.
29. Tsai M, Lu Z, Wientjes MG, et al. Paclitaxel-loaded polymeric microparticles: quantitative relationships between in vitro drug release rate and in vivo pharmacodynamics. J Control Release. 2013;172:737–44.
30. Crison JR, Weiner ND, Amidon GL. Dissolution media for in vitro testing of water-insoluble drugs: effect of surfactant purity and electrolyte on in vitro dissolution of carbamazepine in aqueous solutions of sodium lauryl sulfate. J Pharm Sci. 1997;86:384–8.
31. Bao YM, Mo XP, Xu XY. Stability studies of anticancer agent bis (4-fluorobenzyl) trisulfide and synthesis of related substances. J Pharm Biomed. 2008;48:664–71.
32. El-Laithy HM. Preparation and physicochemical characterization of dioctyl sodium sulfosuccinate (Aerosol OT) microemul sion for oral drug delivery. AAPS PharmSciTech. 2003;4:1–10.
33. Liu TQ, Gao XG. Properties of epigallocatechin-3-Gallate in Tween80 micelle. Acta Phys -Chim Sin. 2010;26:66–72.
34. Illum L, Jordan F, Lewis AL. CriticalSorb™: a novel efficient nasal delivery system for human growth hormone based on Solutol HS15. J Control Release. 2012;162:194–200.
35. Jun LH, Xia YQ, Li D, Zhong LJ, et al. Phospholipid-Tween 80 mixed micelles as an intravenous delivery carrier for paclitaxel. Drug Dev Ind Pharm. 2011;37:597–605.
36. Liu H, Ma XQ. Coenzyme Q10 intravenous infusion and its preparation method: China. 2006. CN200410022007X.
37. Dabholkar RD, Sawant RM, Mongayt DA, et al. Polyethylene glycol–phosphatidylethanolamine conjugate (PEG–PE)-based mixed micelles: some properties, loading with paclitaxel, and modulation of P-glycoprotein-mediated efflux. Int J Pharm. 2006;315:148–57.
38. Win KY, Feng SS. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials. 2005;26:2713–22.
39. Mitri K, Shegokar R, Gohla S, et al. Lipid nanocarriers for dermal delivery of lutein: preparation, characterization, stability and performance. Int J Pharm. 2011;414:267–75.
40. Chen DW, Yan L, Qiao MX, et al. Preparation of docetaxel loaded pH-sensitive block copolymer micelles. Acta Pharm Sin. 2008;43:1066–70.
41. Aguiar J, Carpena P, Molina-Bolívar JA, et al. On the determination of the critical micelle concentration by the pyrene 1:3 ratio method. J Colloid Interface Sci. 2003;258:116–22.
42. Wichit A, Tangsumranjit A, et al. Polymeric micelles of PEG-PE as carriers of all-trans retinoic acid for stability improvement. AAPS PharmSciTech. 2012;13:336–43.
43. Oro JRD. Role of co-solute in biomolecular stability: glucose, urea and the water structure. J Biol Phys. 2001;27:73–9.
44. Wilson B, Lavanya Y, Priyadarshini RAB, et al. Albumin nanoparticles for the delivery of gabapentin: preparation, characterization and pharmacodynamic studies. Int J Pharm. 2014;473:73–9.
45. Venkateswarlu V, Manjunath K. Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. J Control Release. 2004;95:627–38.
46. Torchilin PV. Structure and design of polymeric surfactant-based drug delivery systems. J Control Release. 2011;73:137–72.
47. Bae YH, Yin HQ. Stability issues of polymeric micelles. J Control Release. 2008;131:2–4.